Characterization of hepatitis B virus surface antigen particles expressed in stably transformed mammalian cell lines containing the large, middle and small surface protein
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 183, 104936
Abstract
No abstract availableKeywords
Funding Information
- Agencia Santafesina de Ciencia, Tecnología e Innovación
- Universidad Nacional del Litoral
- Agencia Nacional de Promoción Científica y Tecnológica
This publication has 37 references indexed in Scilit:
- Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 miceVaccine, 2010
- Mammalian Expression of Virus-Like Particles for Advanced Mimicry of Authentic Influenza VirusPLOS ONE, 2010
- Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccineVaccine, 2006
- Quantitative Comparison of Intracellular Trafficking and Nuclear Transcription between Adenoviral and Lipoplex SystemsMolecular Therapy, 2006
- Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccinationThe American Journal of Medicine, 2005
- Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processesGene Therapy, 2005
- Evaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccinesHepatology, 2001
- Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccinesVaccine, 1994
- Inhibition of Secretion of Hepatitis B Surface Antigen by a Related Presurface PolypeptideScience, 1986
- Antibodies to a synthetic peptide from the preS 120–145 region of the hepatitis B virus envelope are virus-neutralizingVaccine, 1986